BIOMAT Database Logo BIOMAT Database Logo

Sexual functioning in women with functional hypothalamic amenorrhea: exploring the relevance of an underlying polycystic ovary syndrome (PCOS)-phenotype. 2023

F Barbagallo, and G Pedrielli, and D Bosoni, and L Tiranini, and L Cucinella, and A E Calogero, and F Facchinetti, and R E Nappi
Department of Clinical and Experimental Medicine, University of Catania, Policlinico "G. Rodolico", via S. Sofia 78, 95123, Catania, Italy. federica.barbagallo11@gmail.com.

OBJECTIVE To study sexual function and distress in women with functional hypothalamic amenorrhea (FHA) compared to women with FHA and an underlying polycystic ovary syndrome (PCOS)-phenotype, considering also their psychometric variables. As a secondary aim, we explored the relationship between sexual functioning and hormonal milieu in these women. METHODS This is a retrospective cross-sectional study conducted on 36 women with typical FHA and 43 women with FHA + PCOS-phenotype. The following validated psychometric questionnaires were administered: Female Sexual Functional Index (FSFI), Female Sexual Distress Scale-Revised (FSDS-R), Body Attitude Test (BAT), Bulimia Investigation Test (BITE), State Anxiety Inventory (STAI), Beck Depression Inventory (BDI), Multidimensional Perfectionism Scale (MPS). Available hormones to formulate FHA diagnosis in the standard routine were considered. RESULTS Women with typical FHA reported a significantly lower FSFI total score than women with FHA + PCOS-phenotype (95% CI for median 16-21.3 vs. 21.1-24.1, p = 0.002), whereas the FSDS-R score was similar in the two groups (95% CI for median 6-16 vs. 6-16.3). No statistically significant differences were evident in body attitude, state and trait anxiety, depression, bulimic risk, and perfectionism between the two groups, confirming the two FHA groups were superimposable from a psychometric perspective. State anxiety correlated negatively with the FSFI total score in both typical FHA (rho: - 0.33, p = 0.05) and FHA + PCOS-phenotype (rho: - 0.40, p = 0.009). In the entire study population, a positive correlation was found between luteinizing hormone, androstenedione, and 17ß-estradiol and the total FSFI score (rho: 0.28, p = 0.01; rho: 0.27, p = 0.01, rho: 0.27, p = 0.01, respectively). CONCLUSIONS Women with FHA showed a very high rate of sexual symptoms as part of their condition, but those with a typical diagnosis displayed a more severe sexual impairment as compared with the FHA + PCOS-phenotype, in spite of a similar psychometric profile. Sexual distress was equally present in both groups (approximately 4 out of 10 women). Further studies should be designed to investigate the potential role of sex hormones, mainly LH-driven androstenedione, in influencing women's sexual functioning.

UI MeSH Term Description Entries
D007986 Luteinizing Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH and FSH), but the beta subunit is unique and confers its biological specificity. ICSH (Interstitial Cell Stimulating Hormone),Interstitial Cell-Stimulating Hormone,LH (Luteinizing Hormone),Lutropin,Luteoziman,Luteozyman,Hormone, Interstitial Cell-Stimulating,Hormone, Luteinizing,Interstitial Cell Stimulating Hormone
D011085 Polycystic Ovary Syndrome A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading. Stein-Leventhal Syndrome,Polycystic Ovarian Syndrome,Polycystic Ovary Syndrome 1,Sclerocystic Ovarian Degeneration,Sclerocystic Ovaries,Sclerocystic Ovary Syndrome,Ovarian Degeneration, Sclerocystic,Ovarian Syndrome, Polycystic,Ovary Syndrome, Polycystic,Ovary, Sclerocystic,Sclerocystic Ovary,Stein Leventhal Syndrome,Syndrome, Polycystic Ovary,Syndrome, Stein-Leventhal
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000568 Amenorrhea Absence of menstruation. Postpartum Amenorrhea,Amenorrhea, Postpartum,Postpartum Amenorrheas
D000735 Androstenedione A delta-4 C19 steroid that is produced not only in the TESTIS, but also in the OVARY and the ADRENAL CORTEX. Depending on the tissue type, androstenedione can serve as a precursor to TESTOSTERONE as well as ESTRONE and ESTRADIOL. 4-Androstene-3,17-dione,delta-4-Androstenedione,4 Androstene 3,17 dione,delta 4 Androstenedione
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

F Barbagallo, and G Pedrielli, and D Bosoni, and L Tiranini, and L Cucinella, and A E Calogero, and F Facchinetti, and R E Nappi
Hypothalamic amenorrhea in young women with underlying polycystic ovary syndrome.
December 2009, Fertility and sterility,
F Barbagallo, and G Pedrielli, and D Bosoni, and L Tiranini, and L Cucinella, and A E Calogero, and F Facchinetti, and R E Nappi
Features of polycystic ovary syndrome (PCOS) in women with functional hypothalamic amenorrhea (FHA) may be reversible with recovery of menstrual function.
April 2018, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
F Barbagallo, and G Pedrielli, and D Bosoni, and L Tiranini, and L Cucinella, and A E Calogero, and F Facchinetti, and R E Nappi
Mood disorders and sexual functioning in women with functional hypothalamic amenorrhea.
November 2010, Fertility and sterility,
F Barbagallo, and G Pedrielli, and D Bosoni, and L Tiranini, and L Cucinella, and A E Calogero, and F Facchinetti, and R E Nappi
Polycystic Ovary-Like Abnormalities (PCO-L) in women with functional hypothalamic amenorrhea.
November 2012, The Journal of clinical endocrinology and metabolism,
F Barbagallo, and G Pedrielli, and D Bosoni, and L Tiranini, and L Cucinella, and A E Calogero, and F Facchinetti, and R E Nappi
Sexual Function and Socio-Sexual Difficulties in Women with Polycystic Ovary Syndrome (PCOS).
May 2019, Geburtshilfe und Frauenheilkunde,
F Barbagallo, and G Pedrielli, and D Bosoni, and L Tiranini, and L Cucinella, and A E Calogero, and F Facchinetti, and R E Nappi
Sexual Functioning among Married Iranian Women with Polycystic Ovary Syndrome.
October 2014, International journal of fertility & sterility,
F Barbagallo, and G Pedrielli, and D Bosoni, and L Tiranini, and L Cucinella, and A E Calogero, and F Facchinetti, and R E Nappi
Endocrine Responses to Triptorelin in Healthy Women, Women With Polycystic Ovary Syndrome, and Women With Hypothalamic Amenorrhea.
June 2023, The Journal of clinical endocrinology and metabolism,
F Barbagallo, and G Pedrielli, and D Bosoni, and L Tiranini, and L Cucinella, and A E Calogero, and F Facchinetti, and R E Nappi
Polycystic Ovary Syndrome Phenotype D Versus Functional Hypothalamic Amenorrhea With Polycystic Ovarian Morphology: A Retrospective Study About a Frequent Differential Diagnosis.
January 2022, Frontiers in endocrinology,
F Barbagallo, and G Pedrielli, and D Bosoni, and L Tiranini, and L Cucinella, and A E Calogero, and F Facchinetti, and R E Nappi
CYP21A2 mutations in women with polycystic ovary syndrome (PCOS).
May 2013, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
F Barbagallo, and G Pedrielli, and D Bosoni, and L Tiranini, and L Cucinella, and A E Calogero, and F Facchinetti, and R E Nappi
The complex relationship between hypothalamic amenorrhea and polycystic ovary syndrome.
April 2008, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!